Clinical Performance of Elecsys® Troponin T hs Gen 6 in Subjects With Symptoms of Acute Coronary Syndrome
Clinical Performance of Elecsys® Troponin T hs Gen 6 in Subjects With Symptoms of Acute Coronary Syndrome
This prospective, non-interventional, single arm, longitudinal cohort multicenter study will recruit approximately 5600 consecutive all-comers, consisting of patients with signs and symptoms of acute coronary syndromes (ACS) who present in the emergency department (ED). The main objective of the study is to determine the clinical performance of Elecsys Troponin T hs Gen 6 versus the centrally adjudicated clinical diagnosis at various time points after ED presentation using the previously determined clinical cut-off of a universal 99th percentile upper reference limit.
Inclusion Criteria:
Age ≥20 years
Signed Informed Consent Form
Troponin or other cardiac marker determination planned as part of suspected acute coronary syndromes routine care
Demonstrating symptoms suggestive of acute coronary syndrome and/or myocardial ischemia, such as any of the following:
Exclusion Criteria:
High Point, North Carolina 27262, United States